Ahmad Sedaghat
Otolaryngology · Cincinnati, OHNPI 1902049687
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $8,423 of the $9,207 with a category attached, or 91.5%. 7 manufacturers reported payments, led by Sanofi at 46.4% of the total. Reporting peaked in 2022 at $4,675 and has fallen 98.4% since, to $77 in 2025. Among otolaryngology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 29 payments — averaging $317.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- GSK$4K
- Aerin Medical Inc.$591
- Optinose US, Inc.$41
- Stryker$24
- Sanofi-aventis U.S. LLC$21
- plus $15 from 1 others
Across 71 payments — averaging $3672.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aerin Medical Inc.$162K
- Regeneron$42K
- GSK$32K
- Sanofi$26K
What the payments were for
- Consulting fees$8,42391%
- Food & beverage$7648%
- Education$210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 12 | $4,272 |
| GSK | 9 | $4,244 |
| Aerin Medical Inc. | 3 | $591 |
| Optinose US, Inc. | 2 | $41 |
| Stryker | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Kaleo, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUCALA$4,155
- DUPIXENT$1,520
- VIVAER STYLUS$104
- RHINAER STYLUS$104
How this compares
$9,207 in reported general payments places this provider in the 90th percentile of 380 otolaryngology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 22 | $80,866 |
| Azelastine Hcl | 257 | $7,398 |
| Mometasone Furoate | 25 | $5,672 |
| Ipratropium Bromide | 113 | $3,511 |
| Budesonide | 16 | $1,970 |
| Fluticasone Propionate | 46 | $1,122 |
| Clarithromycin | 16 | $799 |
| Mupirocin | 126 | $711 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $464 |
| Doxycycline Hyclate | 25 | $259 |
| Omeprazole | 15 | $172 |
| Famotidine | 17 | $121 |
| Prednisone | 20 | $51 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Cincinnati
- Alexander DonathCincinnati$64K
- Katie PhillipsCincinnati$14K
- Aaron FriedmanCincinnati$13K
- Yash PatilCincinnati$11K
- Esther ChengCincinnati$7K
- Lee ZimmerCincinnati$5K
- Matthew HenslerCincinnati$5K
- Joseph HellmannCincinnati$5K
- Thomas TamiCincinnati$4K
- John StaffordCincinnati$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.